Published in Cancer Weekly, January 4th, 2005
A SPA provides a forum for the FDA and a company to reach agreement as to the design, execution, and analyses proposed for regulatory approval in protocols reviewed under this process.
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.